NetraMark Holdings Inc. (TSX:AIAI)
0.9900
+0.0200 (2.06%)
May 22, 2026, 1:53 PM EST
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 10.58K CAD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 175.85K, down -71.65% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%.
Revenue (ttm)
175.85K
Revenue Growth
-71.65%
P/S Ratio
469.43
Revenue / Employee
n/a
Employees
n/a
Market Cap
82.55M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 432.50K | -23.63K | -5.18% |
| Sep 30, 2024 | 456.13K | 366.86K | 410.97% |
| Sep 30, 2023 | 89.27K | -23.76K | -21.02% |
| Sep 30, 2022 | 113.03K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitalhub | 119.20M |
| kneat.com | 66.52M |
| Hydreight Technologies | 35.39M |
| NexgenRx | 18.45M |
| Comprehensive Healthcare Systems | 5.94M |
| Principal Technologies | 370.42K |
| KDA Group | 317.01K |
| AI/ML Innovations | 125.47K |
NetraMark Holdings News
- 12 days ago - NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting - GlobeNewsWire
- 18 days ago - NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum - GlobeNewsWire
- 25 days ago - NetraMark Announces Change To Board Of Directors - GlobeNewsWire
- 27 days ago - NetraMark Holdings Inc. (AIAI) Opens the Market - Newsfile Corp
- 4 weeks ago - NetraMark Appoints Dr. Panteli Theocharous As Fractional Chief Medical Officer, Strengthening Clinical Leadership To Accelerate Global Adoption of NetraAI - GlobeNewsWire
- 4 weeks ago - NetraMark To Open The Market At The Toronto Stock Exchange On May 5, 2026 - GlobeNewsWire
- 5 weeks ago - NetraMark Positioned to Advance Psychedelic Clinical Trials Following U.S. Executive Order, Supported by Peer-Reviewed Research and Active Programs - GlobeNewsWire
- 6 weeks ago - Netramark Comments on U.S. Executive Order to Accelerate Treatments for Serious Mental Illness and Highlights the Need for Regulatory‑Grade Trial Design in Psychedelic Development - GlobeNewsWire